Sleepiness is frequent in parkinsonian patients, increasing with the duration of disease. By patients with motor fluctuations, continuous dopaminergic delivery devices or deep brain stimulation are justified to improve the motor prognosis. Antiparkinsonian treatments, especially dopaminergic agonists, may worsen the sleepiness and thus affect the quality of life. The investigators aimed to monitor sleepiness in parkinsonian patients before and during treatment with continous dopaminergic delivery device or deep brain stimulation.
Study Type
OBSERVATIONAL
Enrollment
30
The investigators measure the objective sleepiness by recording the electro-encephalogramm during four experimental diurnal naps. They also perform a nocturnal polysomnography prior to the tests for a better interpretation.
Nancy University Hospital
Nancy, France
RECRUITINGMean sleep latency
Algebric mean (in minutes) of the sleep latency for the four experimental naps
Time frame: before continuous antiparkinsonian treatment
Mean sleep latency
Algebric mean (in minutes) of the sleep latency for the four experimental naps
Time frame: 6 months after continuous antiparkinsonian treatment
Mean sleep latency
Algebric mean (in minutes) of the sleep latency for the four experimental naps
Time frame: 12 months after continous antiparkinsonian treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.